← Evidence map

ReviewClinical and experimental medicine2023

Calreticulin as a marker and therapeutic target for cancer.

Meilan Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

18 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36335525